Notice is hereby given that the Office of Research Integrity (ORI) has made final findings of scientific misconduct in the following case: Tetsuya Matsuguchi, M.D., Ph.D., Dana-Farber Cancer Institute: On November 3, 1995, ORI found that Tetsuya Matsuguchi, M.D., Ph.D., formerly a Harvard Medical School Research Fellow at the Dana-Farber Cancer Institute, committed scientific misconduct by intentionally falsifying data by artificially darkening one band each on two autoradiographs in figures that he had prepared for a presentation at an intramural research seminar and by altering three bands on the print of an immunoblot included in Figure 2A of a paper published in the EMBO Journal. This research was supported by a Public Health Service grant. Dr. Matsuguchi has entered into a Voluntary Exclusion Agreement with ORI in which he has accepted ORI\'s finding and has agreed to exclude himself voluntarily, for the three (3) year period beginning November 3, 1995: (1) From any contracting or subcontracting with any agency of the United States Government and from eligibility for, or involvement in, Federal nonprocurement transactions (e.g., grants and cooperative agreements), of the United States Government, as defined in 45 C.F.R. Part 76 and 48 C.F.R. Subparts 9.4 and 309.4 (Debarment Regulations); and (2) From serving in any advisory capacity to PHS, including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant. The above voluntary exclusion, however, shall not apply to Dr. Matsuguchi\'s future training or practice of clinical medicine whether as a medical student, resident, fellow, or licensed practitioner unless that practice involves research or research training. Dr. Matsuguchi has agreed to submit a letter to the EMBO Journal requesting correction of the article entitled \`\`Tyrosine phosphorylation of p85\<SUP\>Vav in myeloid cells is regulated by GM-CSF, IL-3, and Steel factor and is constitutively increased by p210\<SUP\>BCR/ ABL\'\' (EMBO Journal 14:257-265, 1995) by retracting Figure 2A, because Dr. Matsuguchi enhanced the Vav bands in lanes 2, 3, and 4 without the knowledge of the other authors, and by substituting the correct Figure 2A.
